Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Effects on Postprandial Lipemia in Metabolic Syndrome
NCT00189085Phase 4Completed
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in metabolic syndrome. Started Dec 2004; status: completed.
02
Drugs
ezetimibe
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00189085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189085.